Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab

The risk of serious bacterial infectious events (SIEs) after an RTX course used in severe and refractory cases of systemic autoimmune diseases (SAID) is well known. Risk factors for SIEs merit investigation. For this case–control study, data were collected in a single centre of internal medicine and...

Descripción completa

Detalles Bibliográficos
Autores principales: Heusele, Marion, Clerson, Pierre, Guery, Benoit, Lambert, Marc, Launay, David, Lefevre, Guillaume, Morell-Dubois, Sandrine, Maillard, Hélène, Le Gouellec, Noémie, Hatron, Pierre-Yves, Hachulla, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058071/
https://www.ncbi.nlm.nih.gov/pubmed/24487486
http://dx.doi.org/10.1007/s10067-014-2509-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058071/
https://www.ncbi.nlm.nih.gov/pubmed/24487486
http://dx.doi.org/10.1007/s10067-014-2509-2

Ejemplares similares